NL194664C - Farmaceutische samenstelling voor het genezen van tumorachtige ziekten. - Google Patents

Farmaceutische samenstelling voor het genezen van tumorachtige ziekten. Download PDF

Info

Publication number
NL194664C
NL194664C NL9220026A NL9220026A NL194664C NL 194664 C NL194664 C NL 194664C NL 9220026 A NL9220026 A NL 9220026A NL 9220026 A NL9220026 A NL 9220026A NL 194664 C NL194664 C NL 194664C
Authority
NL
Netherlands
Prior art keywords
deuterium
water
ppm
tumor
animals
Prior art date
Application number
NL9220026A
Other languages
English (en)
Dutch (nl)
Other versions
NL194664B (nl
NL9220026A (nl
Inventor
Gabor Somlyai
Original Assignee
Gabor Somlyai
Hyd Kutato Fejleszto Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gabor Somlyai, Hyd Kutato Fejleszto Kft filed Critical Gabor Somlyai
Publication of NL9220026A publication Critical patent/NL9220026A/nl
Publication of NL194664B publication Critical patent/NL194664B/xx
Application granted granted Critical
Publication of NL194664C publication Critical patent/NL194664C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NL9220026A 1991-10-31 1992-09-28 Farmaceutische samenstelling voor het genezen van tumorachtige ziekten. NL194664C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU343791 1991-10-31
HU913437A HU208084B (en) 1991-10-31 1991-10-31 Process for producing compositions suitable for curing tumorous diseases
PCT/HU1992/000036 WO1993008794A1 (en) 1991-10-31 1992-09-28 Pharmaceutical products for curing tumorous diseases and process for preparing same
HU9200036 1992-09-28

Publications (3)

Publication Number Publication Date
NL9220026A NL9220026A (nl) 1994-09-01
NL194664B NL194664B (nl) 2002-07-01
NL194664C true NL194664C (nl) 2002-11-04

Family

ID=10964023

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9220026A NL194664C (nl) 1991-10-31 1992-09-28 Farmaceutische samenstelling voor het genezen van tumorachtige ziekten.

Country Status (22)

Country Link
US (1) US5855921A (zh)
JP (1) JP3569916B2 (zh)
KR (1) KR100253874B1 (zh)
CN (1) CN1045162C (zh)
AT (1) AT402692B (zh)
BE (1) BE1006186A3 (zh)
CA (1) CA2122612C (zh)
CH (1) CH685282A5 (zh)
CZ (1) CZ282379B6 (zh)
DE (1) DE4232465B4 (zh)
DK (1) DK170832B1 (zh)
ES (1) ES2077530B1 (zh)
FI (1) FI114010B (zh)
FR (1) FR2683148B1 (zh)
GB (1) GB2276086B (zh)
HU (1) HU208084B (zh)
IT (1) IT1255390B (zh)
LU (1) LU88175A1 (zh)
NL (1) NL194664C (zh)
NO (1) NO307031B1 (zh)
SE (1) SE513624C2 (zh)
WO (1) WO1993008794A1 (zh)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125817C1 (ru) * 1994-01-06 1999-02-10 Хид Кутато-Фейлесто Кфт., Шомяи Габор Пищевой продукт для профилактики развития заболеваний и способ производства пищевых продуктов, пригодных для профилактики развития опухолевых заболеваний
HU214593B (hu) * 1994-03-23 1998-06-29 HYD Kutató-Fejlesztő Kft. Kozmetikai, higiéniai, valamint szépség- és testápoló készítmények és eljárás azok előállítására
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
HU217418B (hu) * 1995-04-20 2000-01-28 László Kótai Kémiai eljárás alacsony deutériumtartalmú víz előállítására
RU2083210C1 (ru) * 1995-09-13 1997-07-10 Николаева Ирина Сергеевна Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
US6444238B1 (en) 2000-03-10 2002-09-03 General Cosmetics Corporation Pain relief composition and method of relieving pain
HU226984B1 (en) * 2001-12-12 2010-04-28 Hyd Kutato Fejlesztoe Kft Medical and food products for treating diabetes mellitus and process for producing thereof
US7449171B2 (en) * 2002-02-12 2008-11-11 The Regents Of The University Of California Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolic products
CA2494715C (en) 2002-07-30 2014-07-08 The Regents Of The University Of California Method for automated, large-scale measurement of the molecular flux rates using mass spectrometry
WO2004022098A1 (en) * 2002-09-09 2004-03-18 Borsos Ferenc Oxygen-enriched water, treated within a magnetic field and heavy water
CA2498378C (en) * 2002-09-13 2013-12-17 The Regents Of The University Of California Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
CA2504313C (en) 2002-11-04 2012-01-17 Marc K. Hellerstein Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
JP2004315487A (ja) * 2003-04-17 2004-11-11 Internatl Scient:Kk 重水素減少水（スーパーライトウォーター）を原料とするスポーツドリンクの飲用による筋肉増強、及び製造方法。
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
US7262020B2 (en) * 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
RO120505B1 (ro) * 2003-08-13 2006-02-28 Institutul Oncologic Profesor Dr. Al. Trestioreanu Metodă pentru stabilirea in vivo la animale de experienţă, a concentraţiei eficiente de apă sărăcită în deuteriu pentru tratamentul cancerului
US20050202406A1 (en) * 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
WO2005070438A1 (en) * 2004-01-23 2005-08-04 Igor Anatolievich Pomytkin Pharmaceutical composition comprising water depleted of heavy isotopes 0-17 and 0-18
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
US20050226825A1 (en) * 2004-04-13 2005-10-13 Giampapa Vincent C Topical composition for preventing and treating skin damage caused by UV light exposure
WO2005117566A1 (ja) * 2004-06-03 2005-12-15 Kunihiro Seki 低重水素濃度食品の生産装置
RO121676B1 (ro) * 2004-08-18 2008-02-28 Institutul Oncologic "Prof.Dr. Al. Trestioreanu" Metodă de creştere a toleranţei organismului la tratamentul cu citostatice
US20080145507A1 (en) * 2005-02-08 2008-06-19 Woodford Associates Limited A U.K. Corporation Alcoholic Beverage Enriched With 1H216O
BRPI0520021A2 (pt) * 2005-02-08 2009-04-14 Woodford Associates Ltd bebidas não alcoólicas enriquecidas com 1h2 16o
KR100928384B1 (ko) * 2005-03-05 2009-11-23 세르게이 파브로비치 솔로비에프 1h216o가 강화된 화장품 조성물
EA012822B1 (ru) * 2005-03-11 2009-12-30 Вада Консалтинг Лимитед Композиции для дезинфекции поверхностей неодушевленных предметов
WO2006096084A1 (en) * 2005-03-11 2006-09-14 Vada Consulting Limited Methods for intradermal, transdermal or transmucosal delivery of biologically active substances
US20080118463A1 (en) * 2005-03-11 2008-05-22 Igor Anatolievich Pomytkin Light Pharmaceutical Water and Therapeutic Compositions and Methods Thereof
RU2275920C1 (ru) * 2005-04-01 2006-05-10 Игорь Анатольевич Помыткин Способ лечения новообразований
US20060251576A1 (en) * 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) * 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
WO2007069932A1 (en) * 2005-12-12 2007-06-21 Vada Consulting Limited Method for suppressing appetite and food intake
US20080299221A1 (en) * 2005-12-12 2008-12-04 Igor Anatolievich Pomytkin Method for Decreasing Postprandial Glucose Excursion
WO2007069934A1 (en) * 2005-12-12 2007-06-21 Vada Consulting Limited Method of treating metabolic syndrome
HUP0900231A2 (hu) * 2009-04-16 2010-11-29 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Allergiás betegségek kezelésére, gyógyítására alkalmas készítmények és eljárás azok elõállítására
DE202009018629U1 (de) 2009-04-21 2012-06-11 Renate Rohlf Gesundheitsförderndes flüssiges Nahrungsmittel
US8658236B2 (en) * 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
US20130129671A1 (en) * 2011-05-27 2013-05-23 Bristol-Myers Squibb Company Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus
HUP1100290A2 (en) 2011-06-01 2012-12-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Combination compositions for the treatment of proliferative diseases
EP2753707A4 (en) 2011-09-08 2015-03-04 Univ California MEASUREMENT OF METABOLIC FLOW, IMAGING AND MICROSCOPY
WO2013086070A1 (en) 2011-12-07 2013-06-13 Glaxosmithkline Llc Methods for determining total body skeletal muscle mass
HUP1200552A2 (en) 2012-09-21 2014-04-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Pharmaceutical compositions for the treatment of high blood pressure
US20150313266A1 (en) * 2012-12-03 2015-11-05 Igor Anatolievich Pomytkin Food for the dietary management of burnout
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
CN103462830A (zh) * 2013-09-03 2013-12-25 大连世纪新源技术开发有限公司 超轻水多肽化妆品及其制备方法
WO2016001643A1 (en) * 2014-06-30 2016-01-07 Mitochondrial Substrate Invention Limited Nutrients solutions for enhancement of cognitive function
RU2601046C1 (ru) * 2015-07-29 2016-10-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") Способ снижения содержания дейтерия в пищевых сельскохозяйственных культурах
AU2017329108B2 (en) * 2016-09-21 2022-07-07 Botanical Water Technologies Ip Ltd Isotopic compositions
WO2019134014A1 (en) 2018-01-02 2019-07-11 Ambrosios Kambouris Isotopic compositions ii
WO2019174659A1 (de) 2018-03-15 2019-09-19 Karl Bau Gmbh Verfahren und anordnung zur herstellung von deuterium reduziertem wasser
CN112811559A (zh) * 2020-12-30 2021-05-18 江苏奥特泉超轻水饮料有限公司 一种低氘氢水及其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3807960A (en) * 1969-08-04 1974-04-30 V Thayer Apparatus for enrichment of deuterium between water and hydrogen sulfide by countercurrent mass transfer
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS56141822A (en) * 1980-04-07 1981-11-05 Hitachi Ltd Method for separating and recovering hydrogen isomer
US4411798A (en) * 1980-05-27 1983-10-25 Standard Oil Company Process for separating D2 O from H2 O using surfactant systems
FR2552324B1 (fr) * 1983-09-23 1985-11-22 Ionescu Pantelimon Dumitru Eau anticancereuse, procede pour sa realisation, outillage pour sa conservation, et methode pour le traitement du cancer
US4874780A (en) * 1987-03-11 1989-10-17 Norsk Hydro A.S. Anticancer compounds
DE3717883A1 (de) * 1987-05-27 1988-12-15 Schiwa Gmbh Verfahren und anordnung zur herstellung von physiologischen loesungen
WO1989001342A2 (en) * 1987-08-07 1989-02-23 Mallinckrodt, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
IL85312A (en) * 1988-02-03 1991-08-16 Israel State Injectable pharmaceutical compositions having improved stability
US4931154A (en) * 1989-07-17 1990-06-05 Southwestern Analytical Chemicals, Inc. Production of metal borohydrides and organic onium borohydrides
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension

Also Published As

Publication number Publication date
JP3569916B2 (ja) 2004-09-29
CZ282379B6 (cs) 1997-07-16
NL194664B (nl) 2002-07-01
AT402692B (de) 1997-07-25
GB2276086B (en) 1995-09-27
HU913437D0 (en) 1992-01-28
FR2683148B1 (fr) 1994-09-09
FI941979A0 (fi) 1994-04-29
GB9408654D0 (en) 1994-07-20
DE4232465B4 (de) 2008-11-06
DK170832B1 (da) 1996-02-05
ES2077530B1 (es) 1996-07-01
LU88175A1 (fr) 1993-03-15
KR930007461A (ko) 1993-05-20
GB2276086A (en) 1994-09-21
FR2683148A1 (fr) 1993-05-07
JPH08501275A (ja) 1996-02-13
NO941590L (zh) 1994-06-23
SE513624C2 (sv) 2000-10-09
IT1255390B (it) 1995-10-31
NO307031B1 (no) 2000-01-31
CN1071836A (zh) 1993-05-12
ITMI922233A0 (it) 1992-09-28
ATA902992A (de) 1996-12-15
SE9401406D0 (sv) 1994-04-25
SE9401406L (sv) 1994-06-07
FI114010B (fi) 2004-07-30
NL9220026A (nl) 1994-09-01
FI941979A (fi) 1994-06-29
CH685282A5 (de) 1995-05-31
US5855921A (en) 1999-01-05
DE4232465A1 (de) 1993-05-06
CN1045162C (zh) 1999-09-22
KR100253874B1 (ko) 2000-04-15
HU208084B (en) 1993-08-30
ITMI922233A1 (it) 1994-03-28
CA2122612A1 (en) 1993-05-13
NO941590D0 (zh) 1994-04-29
ES2077530A1 (es) 1995-11-16
BE1006186A3 (fr) 1994-06-07
WO1993008794A1 (en) 1993-05-13
CA2122612C (en) 2003-02-04
CZ102094A3 (en) 1994-12-15

Similar Documents

Publication Publication Date Title
NL194664C (nl) Farmaceutische samenstelling voor het genezen van tumorachtige ziekten.
US8999424B2 (en) Performance enhancing composition and method of delivering nutrients
EP1465641B1 (de) Arzneimittel enthaltend deuterium zur behandlung der zuckerkrankheit
Hatch et al. Effect of megadoses of ascorbic acid on serum and urinary oxalate
JP2003286167A (ja) エピガロカテキンガレートを含有するアセチルコリンエステラーゼ阻害剤、薬学的製剤及び食品
KR20180002158A (ko) 인삼이 함유된 한약재 추출물을 유효성분으로 함유하는 숙취 해소용 조성물
KR20090091653A (ko) 숙취 예방 및 해소용 조성물
RU2209237C2 (ru) Способ производства пива повышенной биологической ценности
JP2004521854A (ja) 担子菌類とウコギ科植物の有効成分に基づく生理活性組成物
JP6628204B2 (ja) キサンチンオキシダーゼ阻害剤及びその製造方法
JP2003226640A (ja) アルドースリダクターゼ阻害作用剤
JPH08205819A (ja) 保健用飲食品
RU2281012C2 (ru) Способ приготовления биологически активного напитка
KR102658030B1 (ko) 탈염 함초 추출물 또는 이의 분획물을 포함하는 골 질환 또는 갱년기 질환 예방, 치료 또는 개선용 조성물 및 이의 제조 방법
MXPA96003241A (en) Pharmaceutical products to cure tumor diseases and procedure for its preparation
JP2003000211A (ja) 糖尿病の治療・予防用飲料
EP0914091B1 (en) Ethene containing solutions and use thereof in methods of therapy or prophylaxis
JP6901771B2 (ja) ビオチン含有飲料
WO2014045072A2 (en) Pharmaceutical compositions for the treatment of hypertension
US20060122261A1 (en) [method of preparing labdane diterpene composition, preferably isoforskolin and deacetylforskolin from forskolin extract and their use for promoting lean body mass and other applications]
JP2023541986A (ja) チアミン誘導体を含む移植片対宿主疾患予防又は治療用薬学的組成物
KR20200112188A (ko) 보리싹 추출물을 포함한 숙취해소 및 간기능개선용 조성물 및 그 제조방법
NZ527717A (en) Ethene containing solutions and use thereof in methods of therapy
KR20110113707A (ko) 바나듐이 함유된 양파 음료 조성물의 제조방법 및 이에 따라 제조된 바나듐이 함유된 양파 음료 조성물

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20120928